Labeling peptides with rhenium-188

This publication has 10 references indexed in Scilit:

• Preparation, biodistribution, and dosimetry of 188Re-Labeled MoAb ior cea1 and its f(ab′)2 fragments by avidin-biotin strategy
  Nuclear Medicine and Biology, 1999
• Direct Labeling of Monoclonal Antibodies and Antibody Fragments with ¹⁸⁸Re Using a Weak Competing Ligand
  Radiochimica Acta, 1997
• Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA 0 , d -Phe 1 ,Tyr 3 ]octreotide, a promising somatostatin analogue for radionuclide therapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Preparation of 188Re-RC-160 somatostatin analog: a peptide for local/regional radiotherapy
  Applied Radiation and Isotopes, 1997
• Radiolabeled somatostatin analogs in prostate cancer
  Nuclear Medicine and Biology, 1997
• Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with188Re-RC-160, a directly-radiolabeled somatostatin analogue
  International Journal of Cancer, 1996
• Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan)
  Seminars in Nuclear Medicine, 1995
• Rhenium-labeled somatostatin analog RC-160. 1H NMR and computer modeling conformational analysis.
  Journal of Biological Chemistry, 1994
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue
  Biochemical and Biophysical Research Communications, 1988